Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3191793 | Annals of Allergy, Asthma & Immunology | 2012 | 6 Pages |
Abstract
The current analysis showed that omalizumab treatment initiation was associated with significant reductions in ED visits, hospitalizations, and corticosteroid use.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Marie-Hélène MA, Jason PhD, Jie PhD, Mei Sheng MPH, ScD, Boris PharmD, Patrick MA,